Inhibition and Removal of Mature Mixed-Bacteria Biofilms on Voice Prostheses by Sodium Selenite

References

• Kemps GJF, Krebbers I, Pilz W, Vanbelle S, Baijens LWJ. Affective symptoms and swallow-specific quality of life in total laryngectomy patients. Head Neck. 2020;42(11):3179–3187. doi:10.1002/hed.26365
   Web of Science ®Google Scholar
• Scott AJ, McGuire JK, Manning K, Leach L, Fagan JJ. Quality of life after total laryngectomy: evaluating the effect of socioeconomic status. J Laryngol Otol. 2019;133(2):129–134. doi:10.1017/s0022215119000215
   Web of Science ®Google Scholar
• Sharpe G, Camoes Costa V, Doubé W, Sita J, McCarthy C, Carding P. Communication changes with laryngectomy and impact on quality of life: a review. Qual Life Res. 2019;28(4):863–877. doi:10.1007/s11136-018-2033-y
   PubMed Web of Science ®Google Scholar
• Wulff NB, Højager A, Wessel I, Dalton SO, Homøe P. Health-related quality of life following total laryngectomy: a systematic review. Laryngoscope. 2021;131(4):820–831. doi:10.1002/lary.29027
   Web of Science ®Google Scholar
• Lorenz KJ. Stimmrehabilitation nach totaler Laryngektomie: Ein chronologischer, medizinhistorischer Überblick. [Voice rehabilitation after total laryngectomy: a chronological review of medical history]. HNO. 2015;63(10):663–4, 666–80. German. doi:10.1007/s00106-015-0043-4
   Web of Science ®Google Scholar
• Tawfik GM, Makram OM, Zayan AH, et al. Voice rehabilitation by voice prostheses after total laryngectomy: a systematic review and network meta-analysis for 11,918 patients. J Speech Lang Hear Res. 2021;64(7):2668–2681. doi:10.1044/2021_jslhr-20-00597
   Web of Science ®Google Scholar
• Sayed SI, Datta S, Deore N, Kazi RA, Jagade MV. Prevention of voice prosthesis biofilms: current scenario and future trends in prolonging prosthesis lifetime. J Indian Med Assoc. 2012;110(3):175–8, 180.
   Google Scholar
• Tsikopoulos A, Petinaki E, Festas C, et al. In vitro inhibition of biofilm formation on silicon rubber voice prosthesis: α systematic review and meta-analysis. ORL J Otorhinolaryngol Relat Spec. 2022;84(1):10–29. doi:10.1159/000516345
   Web of Science ®Google Scholar
• Oliveira CR, Viana ET, Gonçalves TF, Mateus-Silva JR, Vieira RP. Therapeutic use of intravenous selenium in respiratory and immunological diseases: evidence based on reviews focused on clinical trials. Adv Respir Med. 2022;90(2):134–142. doi:10.5603/ARM.a2022.0018
   Web of Science ®Google Scholar
• Jayachandran P, Knox SJ, Garcia-Cremades M, Savić RM. Clinical pharmacokinetics of oral sodium selenite and dosing implications in the treatment of patients with metastatic cancer. Drugs R D. 2021;21(2):169–178. doi:10.1007/s40268-021-00340-9
   Web of Science ®Google Scholar
• Chen W, An J, Guo J, et al. Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness. Cancer Chemother Pharmacol. 2018;81(5):885–895. doi:10.1007/s00280-018-3561-4
   PubMed Web of Science ®Google Scholar
• Bloos F, Trips E, Nierhaus A, et al. Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA Intern Med. 2016;176(9):1266–1276. doi:10.1001/jamainternmed.2016.2514
   PubMed Web of Science ®Google Scholar
• Chelkeba L, Ahmadi A, Abdollahi M, et al. The effect of high-dose parenteral sodium selenite in critically ill patients following sepsis: a clinical and mechanistic study. Indian J Crit Care Med. 2017;21(5):287–293. doi:10.4103/ijccm.IJCCM_343_16
   Web of Science ®Google Scholar
• Alam MF, Safhi MM, Moni SS, Jabeen A. In vitro antibacterial spectrum of sodium selenite against selected human pathogenic bacterial strains. Scientifica. 2016;2016:9176273. doi:10.1155/2016/9176273
   Google Scholar
• Ticac B, Ticac R, Rukavina T, et al. Microbial colonization of tracheoesophageal voice prostheses (Provox2) following total laryngectomy. Eur Arch Otorhinolaryngol. 2010;267(10):1579–1586. doi:10.1007/s00405-010-1253-8
   Web of Science ®Google Scholar
• Bertl K, Zatorska B, Leonhard M, Matejka M, Schneider-Stickler B. Anaerobic and microaerophilic pathogens in the biofilm formation on voice prostheses: a pilot study. Laryngoscope. 2012;122(5):1035–1039. doi:10.1002/lary.23193
   Web of Science ®Google Scholar
• Buijssen KJ, van der Laan BF, van der Mei HC, et al. Composition and architecture of biofilms on used voice prostheses. Head Neck. 2012;34(6):863–871. doi:10.1002/hed.21833
   Web of Science ®Google Scholar
• Leonhard M, Schneider-Stickler B. Voice prostheses, microbial colonization and biofilm formation. Adv Exp Med Biol. 2015;830:123–136. doi:10.1007/978-3-319-11038-7_8
   Web of Science ®Google Scholar
• Leonhard M, Zatorska B, Moser D, Tan Y, Schneider-Stickler B. Evaluation of combined growth media for in vitro cultivation of oropharyngeal biofilms on prosthetic silicone. J Mater Sci Mater Med. 2018;29(4):45. doi:10.1007/s10856-018-6051-7
   Web of Science ®Google Scholar
• Leonhard M, Tobudic S, Moser D, Zatorska B, Bigenzahn W, Schneider-Stickler B. Growth kinetics of candida biofilm on medical polymers: a long-term in vitro study. Laryngoscope. 2013;123(3):732–737. doi:10.1002/lary.23662
   PubMed Web of Science ®Google Scholar
• Tan Y, Leonhard M, Moser D, Ma S, Schneider-Stickler B. Inhibition of mixed fungal and bacterial biofilms on silicone by carboxymethyl chitosan. Colloids Surf B Biointerfaces. 2016;148:193–199. doi:10.1016/j.colsurfb.2016.08.061
   PubMed Web of Science ®Google Scholar
• Pierce CG, Uppuluri P, Tristan AR, et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3(9):1494–1500. doi:10.1038/nport.2008.141
   PubMed Web of Science ®Google Scholar
• Pentland DR, Stevens S, Williams L, et al. Precision Antifungal Treatment Significantly Extends Voice Prosthesis Lifespan in Patients Following Total Laryngectomy. Front Microbiol. 2020;11:975. doi:10.3389/fmicb.2020.00975
   Web of Science ®Google Scholar
• Ciofu O, Rojo-Molinero E, Macià MD, Oliver A. Antibiotic treatment of biofilm infections. Apmis. 2017;125(4):304–319. doi:10.1111/apm.12673
   PubMed Web of Science ®Google Scholar
• Algburi A, Comito N, Kashtanov D, Dicks LMT, Chikindas ML. Control of biofilm formation: antibiotics and beyond. Appl Environ Microbiol. 2017;83(3). doi:10.1128/aem.02508-16
   Web of Science ®Google Scholar
• Sahal G, Woerdenbag HJ, Hinrichs WLJ, et al. Antifungal and biofilm inhibitory effect of Cymbopogon citratus (lemongrass) essential oil on biofilm forming by Candida tropicalis isolates; an in vitro study. J Ethnopharmacol. 2020;246:112188. doi:10.1016/j.jep.2019.112188
   PubMed Web of Science ®Google Scholar
• Tan Y, Leonhard M, Moser D, Ma S, Schneider-Stickler B. Long-term antibiofilm activity of carboxymethyl chitosan on mixed biofilm on silicone. Laryngoscope. 2016;126(12):E404–e408. doi:10.1002/lary.26096
   Web of Science ®Google Scholar
• Gross M, Ashqar F, Sionov RV, et al. Sustained release varnish containing chlorhexidine for prevention of Streptococcus mutans biofilm formation on voice prosthesis surface: an in vitro study. Int Microbiol. 2022;25(1):177–187. doi:10.1007/s10123-021-00205-w
   Web of Science ®Google Scholar
• Caciandone M, Niculescu AG, Roșu AR, et al. PEG-functionalized magnetite nanoparticles for modulation of microbial biofilms on voice prosthesis. Antibiotics. 2021;11(1). doi:10.3390/antibiotics11010039
   Web of Science ®Google Scholar
• Jirong Y, Huiyun P, Zhongzhe Y, et al. Sodium selenite for treatment of Kashin-Beck disease in children: a systematic review of randomised controlled trials. Osteoarthritis Cartilage. 2012;20(7):605–613. doi:10.1016/j.joca.2012.02.012
   PubMed Web of Science ®Google Scholar
• Narayanan A, Nair MS, Muyyarikkandy MS, Amalaradjou MA. Inhibition and Inactivation of Uropathogenic Escherichia coli Biofilms on Urinary Catheters by Sodium Selenite. Int J Mol Sci. 2018;19(6):Jun. doi:10.3390/ijms19061703
   Web of Science ®Google Scholar
• Han F, Yuan ZT, Liang XL, Xiong YK, Yang M, Ma GQ. 细菌生物被膜耐药机制及天然药物干预的研究进展. [Research advances in drug resistance mechanisms of bacterial biofilm and natural drug intervention]. Zhongguo Zhong Yao Za Zhi. 2021;46(14):3560–3565. Chinese. doi:10.19540/j.cnki.cjcmm.20210318.601
   Google Scholar
• Pereira R. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol. 2021;131(1):11–22. doi:10.1111/jam.14949
   PubMed Web of Science ®Google Scholar
• Singh S, Datta S, Narayanan KB, Rajnish KN. Bacterial exo-polysaccharides in biofilms: role in antimicrobial resistance and treatments. J Genet Eng Biotechnol. 2021;19(1):140. doi:10.1186/s43141-021-00242-y
   PubMed Web of Science ®Google Scholar
• Nett J, Lincoln L, Marchillo K, et al. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother. 2007;51(2):510–520. doi:10.1128/aac.01056-06
   PubMed Web of Science ®Google Scholar
• Tan Y, Ma S, Leonhard M, Moser D, Schneider-Stickler B. β-1,3-glucanase disrupts biofilm formation and increases antifungal susceptibility of Candida albicans DAY185. Int J Biol Macromol. 2018;108:942–946. doi:10.1016/j.ijbiomac.2017.11.003
   Web of Science ®Google Scholar
• Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem. 2015;7(4):493–512. doi:10.4155/fmc.15.6
   PubMed Web of Science ®Google Scholar
• Lynch DJ, Fountain TL, Mazurkiewicz JE, Banas JA. Glucan-binding proteins are essential for shaping Streptococcus mutans biofilm architecture. FEMS Microbiol Lett. 2007;268(2):158–165. doi:10.1111/j.1574-6968.2006.00576.x
   PubMed Web of Science ®Google Scholar